SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19

Affiliations

• ¹ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.
• ² These authors contributed equally to this work: Elizabeth M. Anderson and Caroline Diorio.
• ³ Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
• ⁴ Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
• ⁵ Division of Rheumatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
• ⁶ School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA USA.
• ⁷ Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁸ Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.
• ⁹ Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
• ¹⁰ Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
• ¹¹ Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
• ¹² Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.